Concepedia

Taisuke Matsuya

TM

Statistics

Publications

9

Citations

458

H-Index

9

Active since

2016

Affiliations

Asahikawa Medical University(Current)

Saitama Medical University

Jichi Medical University

Osaka International Cancer Institute

National Hospital Organization

Taisuke Matsuya is an author at Asahikawa Medical University specializing in medicine, oncology, and immunotherapy.

ORCID

Top concepts

Publications per year

2016–2023

9

Publications

9

Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi‐institutional retrospective study

Yasuhiro Nakamura, Ryota Tanaka, Yuri Asami et al. · The Journal of Dermatology · 2016 · 220 citations

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)

Yasuhiro Nakamura, Kenjiro Namikawa, Shusuke Yoshikawa et al. · ESMO Open · 2021 · 50 citations · Full text

Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study

Yoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa et al. · European Journal of Cancer · 2021 · 39 citations

, , +10

Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients

Yasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa et al. · European Journal of Cancer · 2022 · 39 citations

, , +9

Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma

Yasuhiro Nakamura, Yukiko Teramoto, Yuri Asami et al. · JAMA Dermatology · 2017 · 26 citations

, , +13

Rows per page

1–5 of 9